Shengliang Xin

516 total citations
12 papers, 409 citations indexed

About

Shengliang Xin is a scholar working on Epidemiology, Cancer Research and Hepatology. According to data from OpenAlex, Shengliang Xin has authored 12 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 4 papers in Cancer Research and 3 papers in Hepatology. Recurrent topics in Shengliang Xin's work include Liver Disease Diagnosis and Treatment (8 papers), Autophagy in Disease and Therapy (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Shengliang Xin is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Autophagy in Disease and Therapy (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Shengliang Xin collaborates with scholars based in China and United States. Shengliang Xin's co-authors include Keshu Xu, Beibei Liu, Guixin Li, Xiaoling Deng, Junli Zhang, Qianqian Jiang, Ning Zhang, Junli Zhang, Haiming Zhang and Ning Zhang and has published in prestigious journals such as The FASEB Journal, Frontiers in Immunology and Life Sciences.

In The Last Decade

Shengliang Xin

11 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengliang Xin China 9 239 164 64 57 49 12 409
Sha Hu China 8 179 0.7× 175 1.1× 54 0.8× 45 0.8× 23 0.5× 12 354
Qianqian Tu China 9 300 1.3× 180 1.1× 63 1.0× 102 1.8× 42 0.9× 12 640
Hugo Christian Monroy-Ramírez Mexico 13 172 0.7× 209 1.3× 59 0.9× 71 1.2× 34 0.7× 28 527
Hui Qian United States 9 305 1.3× 188 1.1× 42 0.7× 65 1.1× 56 1.1× 13 482
Jiacheng Shen China 12 175 0.7× 121 0.7× 89 1.4× 63 1.1× 27 0.6× 28 479
Estefanía de Gregorio Spain 8 144 0.6× 195 1.2× 35 0.5× 62 1.1× 32 0.7× 8 470
Naihua Hu China 9 141 0.6× 181 1.1× 31 0.5× 52 0.9× 98 2.0× 11 425
A Mahli Germany 12 158 0.7× 193 1.2× 39 0.6× 60 1.1× 126 2.6× 21 472
Qiaohua Kang United States 9 128 0.5× 165 1.0× 90 1.4× 53 0.9× 24 0.5× 11 454
Jianzhi Wu China 15 200 0.8× 195 1.2× 28 0.4× 85 1.5× 90 1.8× 25 483

Countries citing papers authored by Shengliang Xin

Since Specialization
Citations

This map shows the geographic impact of Shengliang Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengliang Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengliang Xin more than expected).

Fields of papers citing papers by Shengliang Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengliang Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengliang Xin. The network helps show where Shengliang Xin may publish in the future.

Co-authorship network of co-authors of Shengliang Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Shengliang Xin. A scholar is included among the top collaborators of Shengliang Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengliang Xin. Shengliang Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Xin, Shengliang, et al.. (2022). Ubiquitin-specific peptidase 10 ameliorates hepatic steatosis in nonalcoholic steatohepatitis model by restoring autophagic activity. Digestive and Liver Disease. 54(8). 1021–1029. 9 indexed citations
2.
Xin, Shengliang, et al.. (2022). USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 9 indexed citations
3.
Xin, Shengliang, et al.. (2022). A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab. Frontiers in Immunology. 13. 1083862–1083862.
4.
Xin, Shengliang, Xia Yang, Yuping Zhang, & Keshu Xu. (2021). Zhikang Capsule Ameliorates Inflammation, Drives Polarization to M2 Macrophages, and Inhibits Apoptosis in Lipopolysaccharide-induced RAW264.7 Cells. Current Medical Science. 41(6). 1214–1224. 2 indexed citations
5.
Liu, Beibei, Xiaoling Deng, Qianqian Jiang, et al.. (2020). Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages. Biomedicine & Pharmacotherapy. 125. 109895–109895. 149 indexed citations
6.
Xin, Shengliang, et al.. (2020). Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis. BMC Gastroenterology. 20(1). 186–186. 25 indexed citations
7.
Xin, Shengliang, et al.. (2020). Abnormal Liver Function Tests of Patients with Coronavirus Disease 2019 in Mainland China: A Systematic Review and Meta- Analysis. Journal of Gastrointestinal and Liver Diseases. 29(2). 219–226. 10 indexed citations
8.
Zhang, Ning, Yuli Wang, Junli Zhang, et al.. (2020). N‐glycosylation of CREBH improves lipid metabolism and attenuates lipotoxicity in NAFLD by modulating PPARα and SCD‐1. The FASEB Journal. 34(11). 15338–15363. 24 indexed citations
9.
Li, Guixin, et al.. (2019). The association of two common polymorphisms in miRNAs with diabetes mellitus. Medicine. 98(40). e17414–e17414. 4 indexed citations
10.
Zhang, Ning, Yuli Wang, Junli Zhang, et al.. (2019). Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice. Molecular Medicine Reports. 20(2). 1363–1372. 21 indexed citations
11.
Liu, Beibei, Xiaoling Deng, Qianqian Jiang, et al.. (2019). Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice. International Immunopharmacology. 75. 105797–105797. 60 indexed citations
12.
Zhang, Junli, Haiming Zhang, Xiaoling Deng, et al.. (2017). Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice. Life Sciences. 192. 46–54. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sha Hu Breakdown of academic impact, for papers by Qianqian Tu Breakdown of academic impact, for papers by Hugo Christian Monroy-Ramírez Breakdown of academic impact, for papers by Hui Qian Breakdown of academic impact, for papers by Jiacheng Shen Breakdown of academic impact, for papers by Estefanía de Gregorio Breakdown of academic impact, for papers by Naihua Hu Breakdown of academic impact, for papers by A Mahli Breakdown of academic impact, for papers by Qiaohua Kang Breakdown of academic impact, for papers by Jianzhi Wu
Rankless by CCL
2026